CHF 50,000,000 Series A Senior Notes due 2034Bruker Corp • August 9th, 2024 • Laboratory analytical instruments
Reference is hereby made to the Note Purchase Agreement dated as of February 1, 2024 (the “Note Purchase Agreement”), entered into by the undersigned, Bruker Corporation (the “Company”) with each of you, relating to the issuance and sale of the Company’s (i) CHF 50,000,000 2.56% Series A Senior Notes due April 15, 2034 (the “Series A Notes”), (ii) CHF 146,000,000 2.62% Series B Senior Notes due April 15, 2036 (the “Series B Notes”) and (iii) CHF 135,000,000 2.71% Series C Senior Notes due April 15, 2039 (the “Series C Notes”, together with the Series A Notes and the Series B Notes, the “Notes”), pursuant to the terms of the Note Purchase Agreement. The terms which are capitalized herein shall have the same meanings as set forth in the Note Purchase Agreement.
CHF 50,000,000 Series A Senior Notes due 2036 CHF 50,000,000 Series B Senior Notes due 2039 of Bruker CorporationBruker Corp • August 9th, 2024 • Laboratory analytical instruments
Reference is hereby made to the Note Purchase Agreement dated as of February 8, 2024 (the “Note Purchase Agreement”), entered into by the undersigned, Bruker Corporation (the “Company”) with each of you, relating to the issuance and sale of the Company’s (i) CHF 50,000,000 2.60% Series A Senior Notes due April 15, 2036 (the “Series A Notes”) and (ii) CHF 50,000,000 2.62% Series B Senior Notes due April 15, 2039 (the “Series B Notes”, together with the Series A Notes, the “Notes”), pursuant to the terms of the Note Purchase Agreement. The terms which are capitalized herein shall have the same meanings as set forth in the Note Purchase Agreement.
